Patents by Inventor Ji-Eun CHA

Ji-Eun CHA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12233113
    Abstract: Provided are a method for administering a recombinant human growth hormone GX-H9 for treating growth hormone deficiency and a pharmaceutical composition containing a recombinant human growth hormone GX-H9 and a pharmaceutically acceptable carrier. The method includes administering recombinant human growth hormone GX-H9 once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: February 25, 2025
    Assignees: GENEXINE, INC., HANDOK INC.
    Inventors: Tae Kyung Kim, Young Joo Ahn, Jung Won Woo, Ji-Eun Cha, Joan Yoon Ji Lee, Woo Ick Jang
  • Publication number: 20230291731
    Abstract: Systems and methods are provided for use in monitoring decentralized data structures including identity attributes, through tokenization of the attributes. One example computer-implemented method includes receiving a request associated with a digital identity including multiple attributes and, for each of the attributes in the request, generating a token specific to the attribute, searching for the generated token in a network graph having multiple stored tokens, and identifying one of the multiple stored tokens as a match to the generated token. The computer-implemented method then further includes, for each of the attributes in the request, retrieving additional ones of the multiple stored tokens linked to the identified one of the stored tokens, comparing the retrieved tokens to the generated token, and promoting the request for further action, in response to at least one of the retrieved tokens being inconsistent with the generated token.
    Type: Application
    Filed: March 10, 2022
    Publication date: September 14, 2023
    Inventors: John O'Neill, Ji Eun Cha, Prashant Sharma, Przemek Praszczalek
  • Publication number: 20210177945
    Abstract: Provided is a method for administering a recombinant human growth hormone GX-H9 for treating growth hormone deficiency. Particularly, the present disclosure relates to a pharmaceutical composition for treating growth hormone deficiency, containing a recombinant hGH GX-H9 and a pharmaceutically acceptable carrier, in which the recombinant GX-H9 is administered once a week with a dosage of 0.1 to 0.3 mg per weight kg of a patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient. Further, the present disclosure relates to a method for treating growth hormone deficiency including administering an recombinant hGH GX-H9 to a patient with growth hormone deficiency once a week with a dosage of 0.1 to 0.3 mg per weight kg of the patient or twice-monthly with a dosage of 0.1 to 0.4 mg per weight kg of the patient.
    Type: Application
    Filed: February 16, 2017
    Publication date: June 17, 2021
    Inventors: Tae Kyung Kim, Young_Joo Ahn, Jung Won Woo, Ji-Eun Cha, Joan Yoon Ji Lee, Woo Ick Jang
  • Publication number: 20190224281
    Abstract: A method for treating growth hormone deficiency, including administering a human growth hormone fusion protein (GX-H9). A method includes administering a pharmaceutical composition containing an hGH fusion protein (GX-H9) and a pharmaceutically acceptable carrier, wherein the fusion protein (GX-H9) is administered once a week at a dose of 0.4 to 1.6 mg per body weight kg of a pediatric patient, or administered once every two weeks at a dose of 0.8 to 3.2 mg per body weight kg of a pediatric patient.
    Type: Application
    Filed: August 30, 2017
    Publication date: July 25, 2019
    Applicants: GENEXINE, INC., HANDOK INC.
    Inventors: Tae Kyung KIM, Jung Won WOO, Joan Yoon Ji LEE, Young-Joo AHN, Ji-Eun CHA, Hyou Young RHIM, Woo Ick JANG